EQT Life Sciences Leads $39 Million Round for Aerska's RNA Therapeutics Innovation EQT Life Sciences has co-led a $39 million Series A financing round to enhance Aerska's technology delivering RNA medicines for neurological diseases, aiming to transform treatment options.

EQT Life Sciences Leads $39 Million Round for Aerska's RNA Therapeutics Innovation #USA #Amsterdam #EQT_Life_Sciences #RNA_Medicines #Aerska

EQT Life Sciences Invests $39 Million in Aerska's RNA Medicine Delivery Technology EQT Life Sciences co-leads a $39 million Series A funding for Aerska, which is developing advanced RNA medicines to treat neurological disorders.

EQT Life Sciences Invests $39 Million in Aerska's RNA Medicine Delivery Technology #Netherlands #Amsterdam #EQT_Life_Sciences #RNA_Medicines #Aerska